中国核工业建设股份有限公司关于子公司引进投资者的公告

Core Viewpoint - China Nuclear Engineering Construction Corporation (CNEC) is introducing investors through its subsidiaries to optimize capital structure and reduce debt, with a total investment of 5 billion yuan aimed at repaying financial institution loans [2][16]. Group 1: Transaction Overview - The subsidiaries involved in this transaction include China Nuclear Engineering No. 2 Construction Co., Ltd., China Nuclear Engineering No. 4 Construction Co., Ltd., China Nuclear Huaxing Construction Co., Ltd., China Nuclear No. 5 Construction Co., Ltd., and China Nuclear Huachen Construction Engineering Co., Ltd. [2] - The total investment amount is 5 billion yuan, with specific allocations of 1.5 billion yuan to China Nuclear No. 2, 800 million yuan to China Nuclear No. 4, 1.5 billion yuan to China Nuclear Huaxing, 800 million yuan to China Nuclear No. 5, and 400 million yuan to China Nuclear Huachen [6][11]. - After the transaction, CNEC will maintain actual control over the five subsidiaries [4][7]. Group 2: Investor Information - The investor, Industrial Bank Financial Asset Investment Co., Ltd. (IB Investment), was established on September 26, 2017, with a registered capital of 27 billion yuan [8]. - As of September 30, 2025, IB Investment reported total assets of 198.192 billion yuan and net assets of 57.772 billion yuan, with a revenue of 5.632 billion yuan and a net profit of 4.425 billion yuan for the first nine months of 2025 [10]. Group 3: Financial and Governance Arrangements - The investment will be used to repay loans from financial institutions, thereby improving the financial health of the subsidiaries [11]. - Post-investment, IB Investment will have the right to nominate one board observer for each subsidiary, allowing participation in governance and management [12]. - Profit distribution will be based on the actual capital contribution, with minimum profit distribution ratios set for each subsidiary [13]. Group 4: Approval Process - The investment proposal was approved by the fourth meeting of the fifth board of directors on December 22, 2025, and does not require shareholder meeting approval [5][17].